Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01328743 · ClinicalTrials.gov registry record · NA

Brief Alcohol Intervention for HIV-Infected Men Who Have Sex With Men (MSM) in a Primary Care Setting

A NA study of HIV and Hazardous Drinking, sponsored by Brown University.

Completed
Registry status
NA
Development phase
180
Enrollment target
1
Study location

NCT01328743: Completed NA study of HIV and Hazardous Drinking, sponsored by Brown University.

NCT01328743 is a NA study of HIV and Hazardous Drinking that has completed, run by Brown University. The registered enrollment target is 180 participants, below the 439-participant average among 303 other HIV trials with a reported enrollment target (59% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01328743, a NA study of HIV and Hazardous Drinking, has completed, sponsored by Brown University.

COMPLETED
Registry status
NA
Development phase
180 participants
Enrollment target
1
Study location

Study Summary

This is a randomized clinical trial to examine the effects of a brief counseling intervention for heavy drinking HIV-infected men who have sex with men compared to HIV care as usual. The study tests the hypothesis that brief counseling will lower drinking in these patients and that reductions in drinking will be associated with better HIV-related outcomes.

Primary Outcome

Number of standard alcoholic drinks consumed per week in the past month

Conditions Studied

Interventions

  • BEHAVIORAL Brief alcohol intervention

Study Locations (1)

Massachusetts

  • Fenway Health - Boston

Trial Details

FieldValue
Enrollment Target 180 participants
Start Date 2011-05
Est. Completion 2016-08
Phase NA
Brown University

231 total trials

What the finished NCT01328743 record still lists

NCT01328743 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 439-participant average among 303 other HIV trials with a reported enrollment target (59% lower).

The record links to 2 conditions, with HIV appearing as the primary indexed condition, and to 1 intervention - of which Brief alcohol intervention is the first listed.

NCT01328743 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT01328743 about?

NCT01328743 is a clinical study titled "Brief Alcohol Intervention for HIV-Infected Men Who Have Sex With Men (MSM) in a Primary Care Setting". This is a randomized clinical trial to examine the effects of a brief counseling intervention for heavy drinking HIV-infected men who have sex with men compared to HIV care as usual. The study tests the hypothesis that brief counseling will lower drinking in these patients and that reductions in dri...

What is the current status of trial NCT01328743?

This trial is currently completed. It is a NA study. The enrollment target is 180 participants. The study started on 2011-05. Estimated completion is 2016-08.

What conditions does trial NCT01328743 study?

This clinical trial studies the following conditions: HIV, Hazardous Drinking.

What interventions are being tested in trial NCT01328743?

The interventions under investigation include: Brief alcohol intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT01328743?

This trial is sponsored by Brown University, which has 231 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01328743 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01328743's enrollment target sits among peer trials

180 120th of 303 higher than 182 of 303 other HIV trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01558804 · 180 participants

    GRoup A StrePtococcus

  • NCT02932176 · 180 participants

    Machine Learning for Handheld Vascular Studies

  • NCT03384563 · 180 participants · Phase 4

    Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane

  • NCT03423628 · 180 participants · Phase 1

    A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01328743, the US trial registry maintained by the National Library of Medicine. NCT01328743 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.